Article Details

Zacks Investment Research Upgrades Recro Pharma (NASDAQ:REPH) to Buy

Retrieved on: 2021-01-04 13:44:33

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Upgrades Recro Pharma (NASDAQ:REPH) to Buy. View article details on hiswai:

Excerpt

WINTON GROUP Ltd acquired a new position in shares of Recro Pharma in the 3rd quarter valued at about $63,000. Finally, Wedbush Securities Inc.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up